Curcumin induces human colon cancer cell death via p62/SQSTM1 degradation, phospho-ERK Up-regulation and ceramide generation

Mahendra Patel, Faisal Thayyullathil, Shahanas Chathoth, Abdulkader Hago, Siraj Pallichankandy, Anees Rahman, Sehamuddin Galadari

Research output: Contribution to journalArticle

Abstract

Curcumin is a natural yellow phenolic compound extracted from the Indian spice, turmeric (Curcuma longa). Several studies demonstrated the ability of curcumin to inhibit events associated with the promotion of cancer. We investigated the effects curcumin on human colon cancer cells in vitro and further examined the molecular mechanisms of curcumin induced cell death. The signaling adapter p62/SQSTM1, a multifunctional protein implicated in autophagy, apoptosis, cell signaling pathways and tumorigenesis, is one of the potential targets for anti-cancer therapy. In this study, we demonstrate a dose and time-dependent down-regulation of p62/SQSTM1 expression by curcumin that correlates with increase in the loss of viability of human colon cancer cells. We also found that curcumin enhanced phospho-ERK expression and ceramide (Cer) generation in human colon cancer cells. However, the present study also shows that, curcumin-induced p62/SQSTM1 degradation, up-regulation of ERK phosphorylation, Cer generation and cell death can be reversed by extracellular anti-oxidants such as glutathione (GSH) and N-acetyl cysteine (NAC). Overall, our results suggest that down regulation of p62/SQSTM1 and up-regulation of phospho-ERK and Cer generation may contribute to the anti-proliferative effects of curcumin against human colon cancer cells.

Original languageEnglish (US)
Pages (from-to)407-417
Number of pages11
JournalCurrent Trends in Biotechnology and Pharmacy
Volume6
Issue number4
StatePublished - Dec 1 2012

Fingerprint

Curcumin
Ceramides
Colonic Neoplasms
Cell Death
Up-Regulation
Curcuma
Down-Regulation
Spices
Autophagy
Oxidants
Cysteine
Neoplasms
Carcinogenesis
Phosphorylation
Apoptosis

Keywords

  • Apoptosis
  • Ceramide
  • Curcumin
  • GSH
  • p62/SQSTM1
  • phospho-ERK

ASJC Scopus subject areas

  • Biotechnology
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Curcumin induces human colon cancer cell death via p62/SQSTM1 degradation, phospho-ERK Up-regulation and ceramide generation. / Patel, Mahendra; Thayyullathil, Faisal; Chathoth, Shahanas; Hago, Abdulkader; Pallichankandy, Siraj; Rahman, Anees; Galadari, Sehamuddin.

In: Current Trends in Biotechnology and Pharmacy, Vol. 6, No. 4, 01.12.2012, p. 407-417.

Research output: Contribution to journalArticle

Patel, Mahendra ; Thayyullathil, Faisal ; Chathoth, Shahanas ; Hago, Abdulkader ; Pallichankandy, Siraj ; Rahman, Anees ; Galadari, Sehamuddin. / Curcumin induces human colon cancer cell death via p62/SQSTM1 degradation, phospho-ERK Up-regulation and ceramide generation. In: Current Trends in Biotechnology and Pharmacy. 2012 ; Vol. 6, No. 4. pp. 407-417.
@article{866d44cac8b945999863bf4abdc3de8a,
title = "Curcumin induces human colon cancer cell death via p62/SQSTM1 degradation, phospho-ERK Up-regulation and ceramide generation",
abstract = "Curcumin is a natural yellow phenolic compound extracted from the Indian spice, turmeric (Curcuma longa). Several studies demonstrated the ability of curcumin to inhibit events associated with the promotion of cancer. We investigated the effects curcumin on human colon cancer cells in vitro and further examined the molecular mechanisms of curcumin induced cell death. The signaling adapter p62/SQSTM1, a multifunctional protein implicated in autophagy, apoptosis, cell signaling pathways and tumorigenesis, is one of the potential targets for anti-cancer therapy. In this study, we demonstrate a dose and time-dependent down-regulation of p62/SQSTM1 expression by curcumin that correlates with increase in the loss of viability of human colon cancer cells. We also found that curcumin enhanced phospho-ERK expression and ceramide (Cer) generation in human colon cancer cells. However, the present study also shows that, curcumin-induced p62/SQSTM1 degradation, up-regulation of ERK phosphorylation, Cer generation and cell death can be reversed by extracellular anti-oxidants such as glutathione (GSH) and N-acetyl cysteine (NAC). Overall, our results suggest that down regulation of p62/SQSTM1 and up-regulation of phospho-ERK and Cer generation may contribute to the anti-proliferative effects of curcumin against human colon cancer cells.",
keywords = "Apoptosis, Ceramide, Curcumin, GSH, p62/SQSTM1, phospho-ERK",
author = "Mahendra Patel and Faisal Thayyullathil and Shahanas Chathoth and Abdulkader Hago and Siraj Pallichankandy and Anees Rahman and Sehamuddin Galadari",
year = "2012",
month = "12",
day = "1",
language = "English (US)",
volume = "6",
pages = "407--417",
journal = "Current Trends in Biotechnology and Pharmacy",
issn = "0973-8916",
publisher = "Association of Biotechnology and Pharmacy",
number = "4",

}

TY - JOUR

T1 - Curcumin induces human colon cancer cell death via p62/SQSTM1 degradation, phospho-ERK Up-regulation and ceramide generation

AU - Patel, Mahendra

AU - Thayyullathil, Faisal

AU - Chathoth, Shahanas

AU - Hago, Abdulkader

AU - Pallichankandy, Siraj

AU - Rahman, Anees

AU - Galadari, Sehamuddin

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Curcumin is a natural yellow phenolic compound extracted from the Indian spice, turmeric (Curcuma longa). Several studies demonstrated the ability of curcumin to inhibit events associated with the promotion of cancer. We investigated the effects curcumin on human colon cancer cells in vitro and further examined the molecular mechanisms of curcumin induced cell death. The signaling adapter p62/SQSTM1, a multifunctional protein implicated in autophagy, apoptosis, cell signaling pathways and tumorigenesis, is one of the potential targets for anti-cancer therapy. In this study, we demonstrate a dose and time-dependent down-regulation of p62/SQSTM1 expression by curcumin that correlates with increase in the loss of viability of human colon cancer cells. We also found that curcumin enhanced phospho-ERK expression and ceramide (Cer) generation in human colon cancer cells. However, the present study also shows that, curcumin-induced p62/SQSTM1 degradation, up-regulation of ERK phosphorylation, Cer generation and cell death can be reversed by extracellular anti-oxidants such as glutathione (GSH) and N-acetyl cysteine (NAC). Overall, our results suggest that down regulation of p62/SQSTM1 and up-regulation of phospho-ERK and Cer generation may contribute to the anti-proliferative effects of curcumin against human colon cancer cells.

AB - Curcumin is a natural yellow phenolic compound extracted from the Indian spice, turmeric (Curcuma longa). Several studies demonstrated the ability of curcumin to inhibit events associated with the promotion of cancer. We investigated the effects curcumin on human colon cancer cells in vitro and further examined the molecular mechanisms of curcumin induced cell death. The signaling adapter p62/SQSTM1, a multifunctional protein implicated in autophagy, apoptosis, cell signaling pathways and tumorigenesis, is one of the potential targets for anti-cancer therapy. In this study, we demonstrate a dose and time-dependent down-regulation of p62/SQSTM1 expression by curcumin that correlates with increase in the loss of viability of human colon cancer cells. We also found that curcumin enhanced phospho-ERK expression and ceramide (Cer) generation in human colon cancer cells. However, the present study also shows that, curcumin-induced p62/SQSTM1 degradation, up-regulation of ERK phosphorylation, Cer generation and cell death can be reversed by extracellular anti-oxidants such as glutathione (GSH) and N-acetyl cysteine (NAC). Overall, our results suggest that down regulation of p62/SQSTM1 and up-regulation of phospho-ERK and Cer generation may contribute to the anti-proliferative effects of curcumin against human colon cancer cells.

KW - Apoptosis

KW - Ceramide

KW - Curcumin

KW - GSH

KW - p62/SQSTM1

KW - phospho-ERK

UR - http://www.scopus.com/inward/record.url?scp=84871702665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871702665&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84871702665

VL - 6

SP - 407

EP - 417

JO - Current Trends in Biotechnology and Pharmacy

JF - Current Trends in Biotechnology and Pharmacy

SN - 0973-8916

IS - 4

ER -